Ethyl cinnamate
VEGFR-2-IN-37
Efdamrofusp alfa
Dilpacimab
Conbercept
Pulocimab
Olinvacimab
Tarcocimab
Ivonescimab
Brolucizumab
ABP 215
Vulinacimab
Ranibizumab (anti-VEGF)
Vanucizumab
Icrucumab
Ramucirumab (anti-VEGFR)
Parsatuzumab
Faricimab
Bevacizumab (PBS)
Anti-Mouse VEGFR-2 Antibody (DC101-Mouse IgG2a)